๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Research directions in paroxysmal nocturnal hemoglobinuria

โœ Scribed by Daniel E Dunn; Russell E Ware; Charles J Parker; Helena O Mishoe; Neal S Young


Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
378 KB
Volume
20
Category
Article
ISSN
0167-5699

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Danazol for paroxysmal nocturnal hemoglo
โœ Harrington, William J.; Kolodny, Luciano; Horstman, Lawrence L.; Jy, Wenche; Ahn ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 45 KB

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal stem-cell disorder in which blood cells lack complement inhibiting membrane proteins, and become susceptible to complement-mediated injury, leading to chronic intravascular hemolysis and pancytopenia. Glucocorticoids have been a mainstay of

Paroxysmal nocturnal hemoglobinuria term
โœ David E. Cowall; Dominick N. Pasquale; Paul Dekker ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 591 KB

A case of a patient who developed erythroleukemia 3 years into the course of paroxysmal nocturnal hemoglobinuria (PNH) is presented. A case of erythroleukemia with a positive sucrose lysis test has been reported, but our case appears to be the first with a long clinical course of PNH evolving into e